ESR1 and breast cancer: To evaluate predicted miRNA-target interactions in [9], the authors focused on the ESR1 protein, showing that ESR1 protein expression in TCGA breast cancer tumors (profiled by RPPA using the antibody ER.alpha.R.V_GBL.9014870) had a strong negative correlation with the expression of predicted miRNA regulators.